Tim Evans
Stock Analyst at Wells Fargo
(2.37)
# 2,503
Out of 5,163 analysts
23
Total ratings
72.73%
Success rate
4.35%
Average return
Main Sectors:
Stocks Rated by Tim Evans
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIO Bio-Rad Laboratories | Maintains: Outperform | $290 → $280 | $262.80 | +6.54% | 2 | Feb 28, 2018 | |
| BIO.B Bio-Rad Laboratories | Maintains: Outperform | $290 → $280 | $264.40 | +5.90% | 2 | Feb 28, 2018 | |
| MEDP Medpace Holdings | Maintains: Market Perform | $38 → $35 | $450.41 | -92.23% | 3 | Feb 28, 2018 | |
| ILMN Illumina | Upgrades: Outperform | n/a | $118.94 | - | 2 | Jan 2, 2018 | |
| WST West Pharmaceutical Services | Maintains: Outperform | $105 → $112 | $235.46 | -52.43% | 4 | Oct 27, 2017 | |
| DGX Quest Diagnostics | Maintains: Market Perform | $88 → $86 | $199.70 | -56.94% | 2 | Oct 20, 2017 | |
| LH Labcorp Holdings | Reinstates: Outperform | $175 | $263.80 | -33.66% | 1 | Oct 12, 2017 | |
| TECH Bio-Techne | Initiates: Market Perform | n/a | $50.85 | - | 1 | Jul 13, 2017 | |
| DHR Danaher | Initiates: Market Perform | $90 | $187.32 | -51.95% | 1 | Jul 13, 2017 | |
| MTD Mettler-Toledo International | Upgrades: Outperform | n/a | $1,173.74 | - | 1 | Jul 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $33.75 | - | 2 | Jul 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $111.51 | - | 1 | Jul 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $0.79 | - | 1 | May 3, 2017 |
Bio-Rad Laboratories
Feb 28, 2018
Maintains: Outperform
Price Target: $290 → $280
Current: $262.80
Upside: +6.54%
Bio-Rad Laboratories
Feb 28, 2018
Maintains: Outperform
Price Target: $290 → $280
Current: $264.40
Upside: +5.90%
Medpace Holdings
Feb 28, 2018
Maintains: Market Perform
Price Target: $38 → $35
Current: $450.41
Upside: -92.23%
Illumina
Jan 2, 2018
Upgrades: Outperform
Price Target: n/a
Current: $118.94
Upside: -
West Pharmaceutical Services
Oct 27, 2017
Maintains: Outperform
Price Target: $105 → $112
Current: $235.46
Upside: -52.43%
Quest Diagnostics
Oct 20, 2017
Maintains: Market Perform
Price Target: $88 → $86
Current: $199.70
Upside: -56.94%
Labcorp Holdings
Oct 12, 2017
Reinstates: Outperform
Price Target: $175
Current: $263.80
Upside: -33.66%
Bio-Techne
Jul 13, 2017
Initiates: Market Perform
Price Target: n/a
Current: $50.85
Upside: -
Danaher
Jul 13, 2017
Initiates: Market Perform
Price Target: $90
Current: $187.32
Upside: -51.95%
Mettler-Toledo International
Jul 13, 2017
Upgrades: Outperform
Price Target: n/a
Current: $1,173.74
Upside: -
Jul 13, 2017
Downgrades: Underperform
Price Target: n/a
Current: $33.75
Upside: -
Jul 13, 2017
Upgrades: Outperform
Price Target: n/a
Current: $111.51
Upside: -
May 3, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $0.79
Upside: -